J33-15388-79557
5 vaccinations
7 coded responses
45 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
S8L-32224-87896
Child or adolescent in my care · Female · 2022-06-28
XGJ-26243-94790
Child or adolescent in my care · Female · 2022-06-28
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Pfizer-BioNTech
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-22
- 2021-03-27
-
2021-04-03
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Health check-in — day 0, dose 2Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-09
- 2021-04-12
- 2021-04-17
-
2021-04-24
Survey response — day 21, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: migraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — day 28, dose 2MedDRA: Dizziness — Feeling: GoodFree text: occasional dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-15
- 2021-07-03
- 2021-10-04
-
2021-10-07
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-07
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Sore throat, swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: sore throat, swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-14
-
2021-10-21
Survey response — day 14, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-27
Call successfulParticipant prefers to complete VAERS report online
- 2021-10-28
-
2021-11-07
Survey response — day 28, dose 3MedDRA: Gastroenteritis viral — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: stomach fluMedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Report sent to call center — day 28, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-09
- 2021-11-11
- 2021-11-11
-
2022-01-06
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2022-08-13
Dose 4 — Pfizer-BioNTech
- 2022-10-07
-
2023-03-17
Dose 5 — Pfizer-BioNTech
- 2023-03-22
- 2023-03-23
- 2023-03-24
- 2023-03-31
- 2023-04-09
- 2023-04-14
- 2023-04-28
- 2023-06-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech | |
| 3 | 2021-10-07 | Pfizer-BioNTech | Flu |
| 4 | 2022-08-13 | Pfizer-BioNTech | No |
| 5 | 2023-03-17 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-21 | Successful 2021-10-27 |
Participant prefers to complete VAERS report online |
| 2021-11-07 | Unsuccessful |
Free text
Release 7 — day 21, dose 2
Symptoms: migraine
Release 8 — day 28, dose 2
Symptoms: occasional dizziness
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat, swollen lymph nodes
Systemic reaction (other): sore throat, swollen lymph nodes
Release 10 — day 14, dose 3
Symptoms: miscarriage
Release 10 — day 28, dose 3
Symptoms: stomach flu
Release 10 — 3 months, dose 3
Symptoms: COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release